News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Recordati S.p.A: 2006 Accounts Approve By the Board. Divident: € 0.185 Per Share (+35%).
March 6, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MILAN, ITALY -- (MARKET WIRE) -- March 06, 2007 -- - 2006 results: Revenue EUR 576.2 million, operating income EUR 120.3 million, net income EUR 74.0 million.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
IPOs
UPDATE: MapLight Seeks $227M IPO for Neuropsych Portfolio
October 7, 2025
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer Beat Out Two Other Metsera Suitors for Takeover
October 7, 2025
·
3 min read
·
Tristan Manalac
Drug pricing
Amgen Hops on DTC Train To Offer Repatha at 60% Discount
October 7, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Most Life Sciences Companies Not Planning New Investments After Tariffs: Report
October 7, 2025
·
3 min read
·
Dan Samorodnitsky
